News
-
-
-
-
PRESS RELEASE
Eurobio Scientific: EB Development obtains a significant majority of the capital with 88.9% held at the end of the Reopened Offer to continue its development with NextStage AM and IK Partners
Eurobio Scientific's EB Development acquires 88.9% of capital in Reopened Offer to continue growth with NextStage AM and IK Partners, supported by Denis Fortier -
-
-
-
-
-